Prime Medicine (PRME) Change in Acquisitions & Divestments (2021 - 2026)

Prime Medicine (PRME) has 6 years of Change in Acquisitions & Divestments data on file, last reported at $50.9 million in Q1 2026.

• Quarterly Change in Acquisitions & Divestments rose 1596.27% year-over-year to $50.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $143.7 million (up 306.72% YoY) and the FY2025 annual result came in at $95.8 million, changed N/A from the prior year.
• Change in Acquisitions & Divestments rose to $50.9 million in Q1 2026, from $39.1 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $72.5 million in Q1 2024 to a low of -$171.3 million in Q4 2024.
• A 5-year average of $21.9 million and a median of $32.5 million in 2022 frame the typical range for Change in Acquisitions & Divestments.
• Annual changes were most pronounced in 2024 — Change in Acquisitions & Divestments plunged 460.37% — and 2026, when it jumped 1596.27%.
• Tracing PRME's Change in Acquisitions & Divestments over 5 years: stood at $25.0 million in 2022, then surged by 90.14% to $47.5 million in 2023, then sank by 460.37% to -$171.3 million in 2024, then jumped by 122.83% to $39.1 million in 2025, then surged by 30.15% to $50.9 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $50.9 million (Q1 2026), $39.1 million (Q4 2025), and $42.4 million (Q3 2025), per Business Quant data.